Multicenter prospective observational study of dupilumab-induced ocular events in atopic dermatitis patients.

Autor: Costedoat I; CHU de Bordeaux, National Reference Center for Rare Skin Diseases, CNRS UMR5164, ImmunoConCept, Univ. Bordeaux, Bordeaux, France., Wallaert M; Department of Dermatology and Ophthalmology, CHU Nantes, UMR 1280 PhAN, INRA, Nantes Université, Nantes, France., Gaultier A; CHU Nantes, Direction de la recherche, Plateforme de Méthodologie et Biostatistique, Nantes Université, Nantes, France., Vasseur R; Department of Dermatology and Ophthalmology, CHU Nantes, UMR 1280 PhAN, INRA, Nantes Université, Nantes, France., Vanhaecke C; Department of Dermatology-Venerology, CHU Robert-Debré, Reims, France., Viguier M; Department of Dermatology-Venerology, CHU Robert-Debré, Reims, France., Cordelette C; Department of Ophthalmology, CHU Robert-Debré, Reims, France., Denoyer A; Department of Ophthalmology, CHU Robert-Debré, Reims, France., Ferrier le Bouëdec MC; Department of Dermatology-Venerology and Ophthalmology, Centre Hospitalier Universitaire Clermont-Ferrand, Clermont-Ferrand, France., Coutu A; Department of Dermatology-Venerology and Ophthalmology, Centre Hospitalier Universitaire Clermont-Ferrand, Clermont-Ferrand, France., Lamiaux M; Department of Dermatology-Venerology and Ophthalmology, Lille Catholic Hospital, Lille Catholic University., Tran THC; Department of Dermatology-Venerology and Ophthalmology, Lille Catholic Hospital, Lille Catholic University., Lacour JP; Department of Dermatology-Venerology and Ophthalmology, University Hospital of Nice-Côte d'Azur, Nice, France., Elmaleh V; Department of Dermatology-Venerology and Ophthalmology, University Hospital of Nice-Côte d'Azur, Nice, France., Tetart F; Department of Dermatology-Venerology and Ophthalmology, Rouen University Hospital, Rouen, France., Gueudry J; Department of Dermatology-Venerology and Ophthalmology, Rouen University Hospital, Rouen, France., Tauber M; Department of Dermatology-Venerology and Ophthalmology, Toulouse, France., Giordano-Labadie F; Department of Dermatology-Venerology and Ophthalmology, Toulouse, France., Cassagne M; Department of Ophthalmology, Toulouse University Hospital, Toulouse, France., Nosbaum A; Centre Hospitalier Lyon Sud, Service d'Allergologie et Immunologie Clinique, Service d'Ophtalmologie, Civils de Lyon, Pierre Bénite, France.; CIRI - Centre International de Recherche en Infectiologie (International Center for Infectiology Research), INSERM U1111, CNRS UMR, Univ Lyon, Lyon, France., Ouilhon C; Centre Hospitalier Lyon Sud, Service d'Allergologie et Immunologie Clinique, Service d'Ophtalmologie, Civils de Lyon, Pierre Bénite, France.; CIRI - Centre International de Recherche en Infectiologie (International Center for Infectiology Research), INSERM U1111, CNRS UMR, Univ Lyon, Lyon, France., Jachiet M; Faculty of Medicine, Assistance Publique-Hôpitaux de Paris (APHP), Department of Dermatology, Saint-Louis Hospital, University of Paris, Paris, France., Tadayoni R; Faculty of Medicine, Assistance Publique-Hôpitaux de Paris (APHP), Department of Ophthalmology, Lariboisiere Hospital, University of Paris, Paris, France., Dezoteux F; Centre de Référence des Syndromes Hyperéosinophiliques, Department of Dermatology-Venerology, CHU Lille, U1286 Inserm INFINITE, Université de Lille, Lille, France., Staumont-Salle D; Centre de Référence des Syndromes Hyperéosinophiliques, Department of Dermatology-Venerology, CHU Lille, U1286 Inserm INFINITE, Université de Lille, Lille, France., Bouleau J; Department of Ophthalmology, CHU Lille, Univ. Lille, Lille, France., Labalette P; Department of Ophthalmology, CHU Lille, Univ. Lille, Lille, France., Doan S; Departement of Dermatology-Venerology and Allergology, Hôpital Tenon, Paris HUEP, APHP, Paris, France.; Sorbonne Université, Paris, France.; Centre d'Immunologie et des Maladies Infectieuses - Paris (Cimi-Paris), INSERM U1135, Paris, France., Soria A; Departement of Dermatology-Venerology and Allergology, Hôpital Tenon, Paris HUEP, APHP, Paris, France.; Sorbonne Université, Paris, France.; Centre d'Immunologie et des Maladies Infectieuses - Paris (Cimi-Paris), INSERM U1135, Paris, France., Mortemousque B; CHU de Bordeaux, National Reference Center for Rare Skin Diseases, CNRS UMR5164, ImmunoConCept, Univ. Bordeaux, Bordeaux, France., Seneschal J; CHU de Bordeaux, National Reference Center for Rare Skin Diseases, CNRS UMR5164, ImmunoConCept, Univ. Bordeaux, Bordeaux, France., Barbarot S; Department of Dermatology and Ophthalmology, CHU Nantes, UMR 1280 PhAN, INRA, Nantes Université, Nantes, France.

Publikováno v: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2023 May; Vol. 37 (5), pp. 1056-1063. Date of Electronic Publication: 2023 Feb 16.

Cellulite de Wells à type d’œdème récidivant du visage : 3 cas

Autor: costedoat, I., Leroy-Colavolpe, V., Dousset, L., Beylot-Barry, M., Doutre, M.S.

Publikováno v: In La revue de médecine interne June 2021 42 Supplement 1:A198-A199

Un cas d’ulcère digital récalcitrant au cours d’une sclérodermie systémique traité par toxine botulique

Autor: Costedoat, I., Amico, S., Seneschal, J., Cogrel, O.

Publikováno v: In Annales de Dermatologie et de Vénéréologie December 2020 147(12) Supplement:A303-A303

Locoregional Treatments for Digital Ulcers in Systemic Sclerosis: A Systematic Review.

Autor: Costedoat I; Department of Dermatology and Paediatric Dermatology, National Reference Center for Rare Skin Diseases, Saint-André Hospital, FR-33000 Bordeaux, France., Masson M, Barnetche T, Duffau P, Lazaro E, Richez C, Seneschal J, Truchetet ME

Publikováno v: Acta dermato-venereologica [Acta Derm Venereol] 2021 Jun 22; Vol. 101 (6), pp. adv00478. Date of Electronic Publication: 2021 Jun 22.

Lichen bulleux déclenché par l’imiquimod chez un patient traité par nivolumab

Autor: Costedoat, I., Dousset, L., Gerard, E., Prey, S., Dutriaux, C., Beylot-Barry, M., Pham-Ledard, A.

Publikováno v: In Annales de Dermatologie et de Vénéréologie December 2019 146(12) Supplement:A325-A325